MSA
EW icon

Marino Stram & Associates’s Edwards Lifesciences EW Stock Holding History

Marino Stram & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
+2,716
New +$228K 0.04% 179
2019
Q2 		– Sell
-1,920
Closed -$122K – 234
2019
Q1 		$122K Buy
1,920
+63
+3% +$3.6K 0.09% 103
2018
Q4 		$95K Sell
1,857
-243
-12% -$12.3K 0.08% 113
2018
Q3 		$122K Hold
2,100
– – 0.1% 108
2018
Q2 		$102K Sell
2,100
-1,800
-46% -$84K 0.09% 120
2018
Q1 		$181K Hold
3,900
– – 0.17% 84
2017
Q4 		$147K Buy
+3,900
New +$143K 0.14% 92

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Marino Stram & Associates's EW Position: Q2 2026 in Review

Marino Stram & Associates opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,716 shares worth $246K. The stake represents 0.04% of the portfolio and ranks #179 among its holdings. This is a return to the name: Marino Stram & Associates previously reported a position in EW as recently as Q1 2019.

Marino Stram & Associates first reported a position in EW in Q4 2017 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Marino Stram & Associates held 2,716 shares of Edwards Lifesciences worth $246K as of Q2 2026.
  • Edwards Lifesciences was a new Marino Stram & Associates position in Q2 2026.
  • Edwards Lifesciences made up 0.04% of Marino Stram & Associates's portfolio in Q2 2026, its #179 holding.
  • Marino Stram & Associates first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 7 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.